Vaccinex - Stock Price History | VCNX

Historical daily share price chart and data for Vaccinex since 2021 adjusted for splits. The latest closing stock price for Vaccinex as of October 15, 2021 is 2.02.
  • The all-time high Vaccinex stock closing price was 11.64 on August 15, 2018.
  • The Vaccinex 52-week high stock price is 9.56, which is 373.3% above the current share price.
  • The Vaccinex 52-week low stock price is 1.64, which is 18.8% below the current share price.
  • The average Vaccinex stock price for the last 52 weeks is 2.49.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vaccinex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.0654 5.0090 8.3700 1.6600 2.0700 -57.32%
2019 5.4312 4.2000 8.1100 3.6683 4.8500 33.07%
2018 7.2785 11.3800 11.6400 3.6448 3.6448 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.062B $0.001B
Vaccinex, Inc. is a clinical-stage immunotherapy company. It engages in the discovery and development of biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. The company's product pipeline consists of VX15, VX5 and VX25 which are in clinical stage. Vaccinex, Inc. is based in Rochester, New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00